Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
FDA Opens Public Docket on Drug Repurposing to Close Labeling Gaps for Approved Medicines
FDA opens a public docket on drug repurposing, targeting labeling updates for approved medicines across metabolic, rare, and neurodegenerative disease areas.
Pharma Now Editorial Team
Reunion Neuroscience Gains FDA Breakthrough Designation for Luvesilocin After Phase 2 PPD Trial Success
Reunion Neuroscience targets 2026 Phase 3 initiation for luvesilocin in PPD after FDA Breakthrough Designation and single-trial registrational agreement.
Pharma Now Editorial Team
FibroBiologics Advances Fibroblast Platform Into Hantavirus Pulmonary Syndrome With No Approved Treatments
FibroBiologics expands its fibroblast platform into Hantavirus pulmonary syndrome, leveraging ARDS preclinical data where no approved treatments exist.
Pharma Now Editorial Team
Abeona Therapeutics Activates CHOP as Sixth Qualified Treatment Center for ZEVASKYN Gene Therapy
Abeona Therapeutics adds CHOP as its sixth ZEVASKYN Qualified Treatment Center, expanding autologous gene therapy access on the US east coast.
Pharma Now Editorial Team
